Anna Rosén

Forskare och överläkare. Leder DIRECT-studien som syftar till att förbättra information till personer med ärftligt ökad risk för cancer. Koordinator för Västerbottens hälsoundersökningar (VHU).

Kontakt

anna.rosen@umu.se

072-453 48 09

Verksam vid

Anknuten som läkare till Institutionen för strålningsvetenskaper Enhet: Onkologi

Målpunkt P01. Regionalt Cancercentrum (RCC), Norrlands universitetssjukhus, Ledningsstaben VLL Umeå universitet, 901 87 Umeå

Anna Rosén arbetar som överläkare på cancergenetiska mottagningen samt är interventionskoordinator för Västerbottens hälsoundersökningar (VHU). Hon leder multicenterstudien DIRECT, som syftar till att utforma och utvärdera nya metoder att informera individer med ärftligt förhöjd risk att drabbas av cancer.

Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden

Hereditary Cancer in Clinical Practice, Springer Nature 2020, Vol. 18

Andersson, Andreas; Hawranek, Carolina; Öfverholm, Anna; et al.

Healthcare professionals' responsibility for informing relatives at risk of hereditary disease

Journal of Medical Ethics

Grill, Kalle; Rosén, Anna

Cancer worry and willingness to undergo colonoscopy at different risk levels: results from a population-based survey in Sweden

European Journal of Human Genetics, Springer Nature 2020, Vol. 28 : 786-786

Hawranek, Carolina; Maxon, J.; Andersson, Andreas; et al.

Prophylactic Mastectomy: Postoperative Skin Flap Thickness Evaluated by MRT, Ultrasound and Clinical Examination

Annals of Surgical Oncology, Springer Nature 2020, Vol. 27 : 2221-2228

Wiberg, Rebecca; Andersson, Magnus N.; Svensson, Johan; et al.

The BRCA1 exon 13 duplication: clinical characteristics of 22 families in Northern Sweden

Familial Cancer, Springer 2019, Vol. 18, (1) : 37-42

Edwinsdotter Ardnor, Christina; Rosén, Anna; Ljuslinder, Ingrid; et al.

Novel variants in Nordic patients referred for genetic testing of telomere-related disorders

European Journal of Human Genetics, Nature Publishing Group 2018, Vol. 26, (6) : 858-867

Norberg, Anna; Rosén, Anna; Raaschou-Jensen, Klas; et al.

Role of HLA-DQ Genotyping in Celiac Disease

Journal of Pediatric Gastroenterology and Nutrition - JPGN, Vol. 62, (3) : E30-E31

Sandström, Olof; Rosén, Anna; Ivarsson, Anneli

Role of HLA-DQ Genotyping in Celiac Disease

Journal of Pediatric Gastroenterology and Nutrition - JPGN, Vol. 62, (3) : E30-E31

Sandström, Olof; Rosén, Anna; Ivarsson, Anneli

High adherence to a gluten-free diet in adolescents with screening-detected celiac disease

Journal of Pediatric Gastroenterology and Nutrition - JPGN, Lippincott Williams & Wilkins 2015, Vol. 60, (1) : 54-59

Webb, Charlotta; Myléus, Anna; Norström, Fredrik; et al.

Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening

Journal of Pediatric Gastroenterology and Nutrition - JPGN, Lippincott Williams & Wilkins 2015, Vol. 60, (6) : 787-791

Webb, Charlotta; Norström, Fredrik; Myléus, Anna; et al.

Internalizing the threat of risk: a qualitative study about adolescents' experience living with screening-detected celiac disease 5 years after diagnosis

Health and Quality of Life Outcomes, BioMed Central 2014, Vol. 12

Nordyke, Katrina; Rosén, Anna; Emmelin, Maria; et al.

Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants

Gut, Vol. 63, (3) : 415-422

Romanos, Jihane; Rosén, Anna; Kumar, Vinod; et al.

Usefulness of symptoms to screen for celiac disease

Pediatrics, Vol. 133, (2) : 211-218

Rosén, Anna; Sandström, Olof; Carlsson, Annelie; et al.

Body mass index is not a reliable tool in predicting celiac disease in children

BMC Pediatrics, BioMed Central 2014, Vol. 14 : 165-

van der Pals, Maria; Myléus, Anna; Norström, Fredrik; et al.

Prevalence of childhood celiac disease and changes in infant feeding

Pediatrics, Vol. 131, (3) : e687-e694

Ivarsson, Anneli; Myléus, Anna; Norström, Fredrik; et al.

BMC Public Health, BioMed Central 2013, Vol. 13

Nordyke, Katrina; Norström, Fredrik; Lindholm, Lars; et al.

Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in a sequential testing

Journal of Pediatric Gastroenterology and Nutrition - JPGN, Lippincott Williams & Wilkins 2013, Vol. 57, (4) : 472-476

Sandström, Olof; Rosén, Anna; Lagerqvist, Carina; et al.

Mass screening for celiac disease in 12-year-olds: Finding them and then what?

Umeå University medical dissertations, 1520

Rosén, Anna

Mass screening for celiac disease from the perspective of newly diagnosed adolescents and their parents: A mixed-method study

BMC Public Health, BioMed Central 2011, Vol. 11 : 822-

Rosén, Anna; Emmelin, Maria; Carlsson, Annelie; et al.

Balancing health benefits and social sacrifices: a qualitative study of how screening-detected celiac disease impacts adolescents' quality of life

BMC Pediatrics, BioMed Central 2011, Vol. 11 : 32-

Rosén, Anna; Ivarsson, Anneli; Nordyke, Katrina; et al.

The preventCD study design: towards new strategies for the prevention of coeliac disease

European Journal of Gastroenterology and Hepathology, Vol. 22, (12) : 1424-1430

Hogen Esch, Caroline Elisabeth; Rosén, Anna; Auricchio, Renata; et al.

Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic

Journal of Pediatric Gastroenterology and Nutrition - JPGN, New York: Raven P 2009, Vol. 49, (2) : 170-176

Myléus, Anna; Ivarsson, Anneli; Webb, Charlotta; et al.

Reduced prevalence of childhood celiac disease: an effect of changes in infant feeding?

Ivarsson, Anneli; Myléus, Anna; Norström, Fredrik; et al.

Symptoms do not predict celiac disease in a mass screening of Swedish 12-year-olds

Rosén, Anna; Sandström, Olof; Carlsson, Annelie; et al.

Visa publikationer i DiVA

Forskningsprojekt

2 september 2019 till 31 december 2021

DIRECT-studien - Genetisk riskinfo för att förebygga cancer

Undervisar på läkarprogrammet, biomedicinarprogrammet, specialistutbildning för onkologisjuksköterskor, samt vid fortbildning för AT-och ST-läkare.

Ämnen:

prevention
folkhälsoarbete
screening
klinisk genetik
ärftlig cancer
etik och genetik
forskningsmetodik
kvalitativ forskningsmetodik
epidemiologi

Publicerad: 12 nov, 2020

Nya Cancerfondsmiljoner till forskning vid Umeå universitet

Publicerad: 11 nov, 2020

Svenskar vill veta risk för ärftlig cancer

Publicerad: 03 okt, 2018

Forte beviljar drygt 50 miljoner till Umeåforskare